Home
Herriot Tabuteau, CEO: Axsome Therapeutics AXSM Sell · Filed 25/12/04
Trade details
- Type
- Insider sale
- Amount
- $7,121,346.68
- Shares · price
- 49,252 sh · $144.59 a share
- Held after
- 7,229 sh
- Person
- Herriot TabuteauCEO
- Trade date
- 25/12/02
- Filed
- 25/12/04
- Days to filing
- 2 days
Sold 87.2% of holdings
- Share of holding sold
- 87.2%
Axsome Therapeutics trades, last 26 weeks
What else happened in Axsome Therapeutics around then
Filed or reported within 30 days of the trade day · 25/11/02~01/01Herriot Tabuteau's recent trades
- Herriot Tabuteau
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 planAxsome Therapeutics
AXSM
$979.2K
4,660 sh
$979.2K
Filed 08/06
Traded 08/06
- Herriot Tabuteau
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 planAxsome Therapeutics
AXSM
$9.6M
45,004 sh
$9.6M
Filed 08/05
Traded 08/05
- Herriot Tabuteau
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 planAxsome Therapeutics
AXSM
$12M
49,666 sh
$12M
Filed 07/01
Traded 07/01
- Herriot Tabuteau
Planned sale10b5-1 planAxsome Therapeutics
Planned sale10b5-1 planAxsome Therapeutics
AXSM
$12.2M
49,670 sh
$12.2M
Filed 06/09
Traded 06/09
- Herriot Tabuteau
Sell10b5-1 planAxsome Therapeutics
Sell10b5-1 planAxsome Therapeutics
AXSM
$12M
49,670 sh
$12M
Filed 06/09
Traded 06/09